DaShenLin Pharmaceutical Group Co., Ltd.
DaShenLin Pharmaceutical Group Co., Ltd. is number 1514 in the 311 Titans Index of the world's largest companies, with reported revenue of about $3.8bn in 2025. It is headquartered in Guangzhou, China.
Part of the 311 Titans Index (311institute.com). Last updated .
Ownership
No shareholder controls the company: the largest, 柯云峰, holds 21.3% (as of 2026-06-30).
Other Titans in China
- PetroChina Company Limited (#9)
- China Petroleum and Chemical Corporation (#10)
- China State Construction Engineering Corporation Limited (#15)
- JD.com, Inc. (#33)
- China State Railway Group (#34)
- China Railway Group Limited (#38)
- China Mobile Limited (#41)
- Alibaba Group (#42)
- China Railway Construction Corporation Limited (#43)
- Foxconn Industrial Internet Co., Ltd (#49)
- Tencent Holdings Limited (#59)
- China Communications Construction Company Limited (#63)
- Xiamen C and D Inc. (#73)
- SAIC Motor Corporation Limited (#74)
- Power Construction Corporation of China, Ltd. (#75)
- BYD Company (#91)
- Wuchan Zhongda Group Co., Ltd. (#93)
- Shandong Weiqiao Pioneering Group (#94)
- Jiangxi Copper Company Limited (#99)
- China Telecom Corporation Limited (#106)
- Midea Group Co., Ltd. (#116)
- Metallurgical Corporation of China Ltd. (#118)
- China Energy Engineering Corporation Limited (#120)
- Contemporary Amperex Technology Co., Limited (#132)
- Xiamen Xiangyu Co., Ltd. (#136)
- CNOOC Limited (#139)
- China United Network Communications Limited (#144)
- Meituan (#157)
- Zijin Mining Group Co., Ltd. (#159)
- Xiamen ITG Group Corp., Ltd. (#163)
Related
Questions and answers
How big is DaShenLin Pharmaceutical Group Co., Ltd.?
DaShenLin Pharmaceutical Group Co., Ltd. reported revenue of about $3.8bn in 2025, ranking number 1514 in the 311 Titans Index.
Where is DaShenLin Pharmaceutical Group Co., Ltd. headquartered?
DaShenLin Pharmaceutical Group Co., Ltd. is headquartered in Guangzhou, China.
Source: official filing (filing), retrieved 5 October 2026. Revenue converted to US dollars at the ECB average rate for the financial year.
© 311 Institute 2026. Facts from official filings, Wikidata (CC0) and the sources linked on this page. The selection, classification and links are the proprietary work of the 311 Institute, protected by copyright and database rights.